Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

ANIXA BIOSCIENCES INC Current Ratio 2010-2022 | ANIX

ANIXA BIOSCIENCES INC current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
ANIXA BIOSCIENCES INC Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-10-31 $0.03B $0.00B 14.83
2022-07-31 $0.03B $0.00B 22.02
2022-04-30 $0.03B $0.00B 27.39
2022-01-31 $0.04B $0.00B 19.58
2021-10-31 $0.04B $0.00B 28.35
2021-07-31 $0.04B $0.00B 30.67
2021-04-30 $0.04B $0.00B 26.66
2021-01-31 $0.02B $0.00B 9.55
2020-10-31 $0.01B $0.00B 7.88
2020-07-31 $0.01B $0.00B 7.64
2020-04-30 $0.01B $0.00B 5.25
2020-01-31 $0.01B $0.00B 5.21
2019-10-31 $0.01B $0.00B 4.11
2019-07-31 $0.01B $0.00B 4.59
2019-04-30 $0.01B $0.00B 4.70
2019-01-31 $0.01B $0.00B 4.70
2018-10-31 $0.01B $0.00B 4.38
2018-07-31 $0.01B $0.00B 5.06
2018-04-30 $0.01B $0.00B 4.27
2018-01-31 $0.01B $0.00B 5.32
2017-10-31 $0.01B $0.00B 7.89
2017-07-31 $0.01B $0.00B 2.20
2017-04-30 $0.01B $0.00B 1.42
2017-01-31 $0.00B $0.00B 0.56
2016-10-31 $0.00B $0.00B 7.25
2016-07-31 $0.00B $0.00B 7.54
2016-04-30 $0.01B $0.00B 6.79
2016-01-31 $0.01B $0.00B 4.97
2015-10-31 $0.01B $0.00B 11.61
2015-07-31 $0.01B $0.00B 10.90
2015-04-30 $0.01B $0.00B 12.38
2015-01-31 $0.01B $0.00B 6.34
2014-10-31 $0.01B $0.00B 3.49
2014-07-31 $0.01B $0.01B 0.77
2014-04-30 $0.00B $0.01B 0.34
2014-01-31 $0.00B $0.01B 0.29
2013-10-31 $0.00B $0.00B 0.38
2013-07-31 $0.00B $0.00B 0.33
2013-04-30 $0.00B $0.00B 0.40
2013-01-31 $0.00B $0.00B 0.52
2012-10-31 $0.00B $0.00B 0.51
2012-07-31 $0.00B $0.00B 0.64
2012-04-30 $0.00B $0.00B 0.84
2012-01-31 $0.00B $0.00B 1.27
2011-10-31 $0.00B $0.00B 1.48
2011-07-31 $0.00B $0.00B 1.25
2011-04-30 $0.00B $0.00B 3.23
2011-01-31 $0.00B $0.00B 1.87
2010-10-31 $0.00B $0.00B 2.74
2010-07-31 $0.00B $0.00B 3.10
2010-04-30 $0.00B $0.00B 5.07
2010-01-31 $0.00B $0.00B 5.43
2009-10-31 $0.00B $0.00B 6.05
2009-07-31 $0.00B $0.00B 10.28
2009-04-30 $0.00B $0.00B 5.24
2009-01-31 $0.00B $0.00B 4.16
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.141B $0.001B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00